Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell ... MarketWatch Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO. MEL200 demonstrated a longer median PFS and OS compared ... MEL200 demonstrated a longer median PFS and OS compared to MPR in the ... ASCO 2012 Multiple Myeloma Update – Day Three: Poster Presentations |
